advanced search
Tomohiro Suzuki
Associate General Manager
Mitsubishi Gas Chemical

Is this your profile?

About

Tomohiro Suzuki graduated from Waseda University (Japan) in 1997 and joined MGC in 1998. He belonged to the Oxygen Absorbers Division until 2011, after which he was transferred to the Advanced Business Development Division in 2012 to be a member of the OXYCAPT development team. Since then, he has been in charge of marketing for the OXYCAPT vial and syringe. His current position is Associate General Manager

Contributions

INJECTION
CONTAINER CLOSURE INTEGRITY OF OXYCAPT™ VIAL AT -80°C WITH DRY ICE
Hiroki Hasegawa and Tomohiro Suzuki highlight the overall benefits of OXYCAPT, Mitsubishi Gas Chemical’s multilayer plastic vial, as a primary container for biologics and gene and cell therapies and discuss the company’s recent investigation into OXYCAPT’s performance at -80°C under dry ice conditions.

More contributions

PREFILLED SYRINGES
NEW EXTRACTABLES DATA FOR OXYCAPT™ MULTILAYER PLASTIC VIAL FOR BIOLOGICS & GENE/CELL THERAPY
Hiroki Hasegawa and Tomohiro Suzuki review the properties of OXYCAPT™, Mitsubishi Gas Chemical’s multilayer material for primary biologic packaging, and share the data from the latest study on OXYCAPT’s extractables profile.
INJECTION
OXYCAPT: SUPERIOR PRIMARY CONTAINERS FOR BIOLOGICS AND GENE AND CELL THERAPIES
Tomohiro Suzuki reviews the advantages that OXYCAPT™, Mitsubishi Gas Chemical's multilayer material for vials, offers to biologics and gene and cell therapies, and discusses the results of recent tests into low-temperature storage and dimethyl sulfoxide resistance.
PREFILLED SYRINGES
OXYCAPT: SUPERIOR PRIMARY CONTAINERS FOR BIOLOGICS AND GENE AND CELL THERAPIES
Yasuaki Yoshimura and Tomohiro Suzuki review the advantages that OXYCAPT, the company’s multilayer material for vials, offers to biologics and gene and cell therapies, and discuss the results of recent tests into low temperature storage and dimethyl sulfoxide resistance.
PREFILLED SYRINGES
OXYCAPT™: A SUPERIOR PRIMARY CONTAINER MATERIAL FOR BIOLOGICS AND GENE AND CELL THERAPIES
Hiroki Hasegawa and Tomohiro Suzuki provide an overview of the OXYCAPT multilayer vial and syringe, along with a discussion of how OXYCAPT fares at low and very low temperatures.
PREFILLED SYRINGES
PHOTO-STABILITY TESTS OF EPINEPHRINE
Yoshiko Sakuma and Tomohiro Suzuki provide an overview of OXYCAPT multilayer vial and syringe, with a particular emphasis on the advantages of OXYCAPT as a container for adrenaline, as demonstrated by recent studies conducted by MGC.
PREFILLED SYRINGES
PHOTOSTABILITY TESTS OF ANTIBODY DRUGS
Yoshiko Sakuma and Tomohiro Suzuki provide an overview of Mitsubishi Gas Chemical's OXYCAPT multilayer vial and syringe, with a particular focus on the recent investigations into the interaction of OXYCAPT’s UV barrier with the photostability of antibody drugs, compared with standard cyclo-olefin polymer and Type 1 glass.
INDUSTRIALISATION
UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
Hiroki Hasegawa and Tomohiro Suzuki discuss the advantages of OXYCAPT™ multilayer plastic vial and syringe, which combine the benefits of cyclo-olefin polymer with excellent oxygen and UV barrier properties. In particular, the authors focus on recent studies that highlight OXYCAPT’s very low levels of extractables.
PREFILLED SYRINGES
OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
Shota Arakawa and Tomohiro Suzuki discuss MGC’s OXYCAPT™ vial and syringe primary containers, including the OXYCAPT™ material and product offering, as well as where MGC sees OXYCAPT™ fitting into the modern pharmaceutical market.
PREFILLED SYRINGES
UPDATE ON OXYCAPT MULTILAYER PLASTIC VIAL AND SYRINGE
Tomohiro Suzuki gives an update, including new oxygen barrier data, on the development of the OXYCAPT™ multilayer plastic vial and syringe.
PREFILLED SYRINGES
OXYCAPT MULTILAYER PLASTIC VIAL AND SYRINGE
Shota Arakawa and Tomohiro Suzuki, discuss the benefits of the OXYCAPT™ multilayer plastic vial and syringe for the rapidly growing field of biologics and regenerative medicines.
PREFILLED SYRINGES
LATEST UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
Tomohiro Suzuki gives an update on the development of the OXYCAPT™ multilayer plastic vial and syringe – highlighting the results of recent tests comparing it with existing glass syringes.
WEARABLES
ADVANCES IN MULTILAYER TECHNOLOGY FOR WEARABLE INJECTOR PRIMARY PACKAGING
Hiroki Hasegawa and Tomohiro Suzuki discuss how multilayer technology used in the drinks bottle industry can be used to create syringes and vials for biologics, avoiding problems such as oxidation and absorption that occur with other materials.
Figure 1: OXYCAPT™ Vials and Syringes.
INJECTION
MULTILAYER PLASTIC VIALS & SYRINGES FOR BIOLOGICS
Dr Takuya Minezaki and Tomohiro Suzuki, provide an overview of the company’s OXYCAPT™ Vials and Syringes, explaining how their multi-layered polymer material delivers the advantages of both COP and glass, and is especially suitable for biotherapeutics.
PREFILLED SYRINGES
MULTILAYER PLASTIC VIALS & SYRINGES FOR BIOLOGICS
Shota Arakawa and Tomohiro Suzuki discuss OXYCAPT™ Plastic Vial and Syringe, which provides a product with all the advantages of plastic, coupled with strong oxygen and UV barrier properties.
PREFILLED SYRINGES
ADVANCED MULTILAYER POYLMER VIAL & SYRINGE FOR BIOLOGICS
Tomohiro Suzuki explains how MGC has developed OXYCAPT™ Vial & Syringe to overcome the current weaknesses of glass and cyclo-olefin polymer containers, developing a product that provides the advantages of both.
Top